Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Nicox receives FDA approval of ZERVIATE (cetirizine ophthalmic solution) 0.24%

May 31, 2017

View Press Release Corporate presentation Contact us
Previous